Innovative antibody drug therapies against cancer (Mainz)
Event date: 14 October 2015
Ganymed Pharmaceuticals AG, partner in the cluster for individualised immune intervention (Ci3) in Mainz, opened its doors to the public. More than 50 attendees used the opportunity to gain insight into the company’s history and the development of innovative antibody therapies against cancer. The highlight of the event was a guided tour through the laboratories. There,visitors were able to witness the day to day work in medical research and development, and learn about important lab methods. Thereafter, a gathering around poster presentations, offered visitors further information about the company’s current research projects and networking.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.